Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients

Details for Australian Patent Application No. 2011223906 (hide)

Owner Agnello, V.

Inventors Agnello, Vincent

Agent Freehills

Pub. Number AU-A-2011223906

PCT Pub. Number WO2011/109285

Priority 61/309,161 01.03.10 US

Filing date 28 February 2011

Wipo publication date 9 September 2011

International Classifications

G01N 33/569 Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/08 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C12Q 1/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109285 Priority application(s): WO2011/109285

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223918-Adaptive visual performance testing system

2011223900-Methods for purifying cells derived from pluripotent stem cells